Evidence map›Paper›PMID 17503334›Full record

ArticleAmerican journal of human genetics2007

A genomewide admixture mapping panel for Hispanic/Latino populations.

Xianyun Mao, Abigail W Bigham, Rui Mei, Gerardo Gutierrez, Ken M Weiss, Tom D Brutsaert, Fabiola Leon-Velarde, Lorna G Moore, Enrique Vargas, Paul M McKeigue and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 4 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 4 syntheses or guidelines pooled it, 244 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Xianyun MaoDepartment of Anthropology, The Pennsylvania State University, University Park, PA 16801, USA.
Abigail W Bigham
Rui Mei
Gerardo Gutierrez
Ken M Weiss
Tom D Brutsaert
Fabiola Leon-Velarde
Lorna G Moore
Enrique Vargas
Paul M McKeigue
Mark D Shriver
Esteban J Parra
Pennsylvania State University · USUniversidad Peruana Cayetano Heredia · PEUniversity College Dublin · IEUniversidad Mayor de San Andrés · BOUniversity at Albany, State University of New York · USUniversity of Toronto · CA

Funding

Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
CONSTRUCTION AND APPLICATION OF A US ADMIXTURE MAPR01HG002154 · NHGRI · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI SHRIVER, MARK D · 1999 to 2006
$1.7M
CHRONIC HYPOXIA, UTERINE ARTERY VASOREGULATION &GROWTHR01HL060131 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MOORE, LORNA G. · 1999 to 2003
$1.3M
NHGRI NIH HHS HG02154NHGRI NIH HHS R01 HG002154NHLBI NIH HHS HL07171NHLBI NIH HHS HL60131NHLBI NIH HHS T32 HL007171PHS HHS TN01188
6 · The paper itself

Abstract

Admixture mapping (AM) is a promising method for the identification of genetic risk factors for complex traits and diseases showing prevalence differences among populations. Efficient application of this method requires the use of a genomewide panel of ancestry-informative markers (AIMs) to infer the population of origin of chromosomal regions in admixed individuals. Genomewide AM panels with markers showing high frequency differences between West African and European populations are already available for disease-gene discovery in African Americans. However, no such a map is yet available for Hispanic/Latino populations, which are the result of two-way admixture between Native American and European populations or of three-way admixture of Native American, European, and West African populations. Here, we report a genomewide AM panel with 2,120 AIMs showing high frequency differences between Native American and European populations. The average intermarker genetic distance is ~1.7 cM. The panel was identified by genotyping, with the Affymetrix GeneChip Human Mapping 500K array, a population sample with European ancestry, a Mesoamerican sample comprising Maya and Nahua from Mexico, and a South American sample comprising Aymara/Quechua from Bolivia and Quechua from Peru. The main criteria for marker selection were both high information content for Native American/European ancestry (measured as the standardized variance of the allele frequencies, also known as "f value") and small frequency differences between the Mesoamerican and South American samples. This genomewide AM panel will make it possible to apply AM approaches in many admixed populations throughout the Americas.

Indexed as

Chromosome MappingGenome, HumanAllelesBlack or African AmericanBlack PeopleChromosomes, HumanGene FrequencyGenetic LinkageGenetic MarkersGenetics, PopulationGenetic TestingGenotypeHispanic or LatinoHumansIndians, Central AmericanIndians, North AmericanGenetic Markers

Identifiers

PMID17503334
PMCPMC1867104
OpenAlexW2045147858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.